Tasly Pharmaceutical Group Co Ltd
Tasly Pharmaceutical Group's GHG Emissions Data Preview
In 2024, Tasly Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Tasly Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Tasly Pharmaceutical Group's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Tasly Pharmaceutical Group amounted to 143,697.01 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Tasly Pharmaceutical Group increased by 7.1%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Tasly Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Tasly Pharmaceutical Group's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Tasly Pharmaceutical Group were 37,369.84 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2023), Tasly Pharmaceutical Group's Scope 1 emissions decreased by 2.76%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Tasly Pharmaceutical Group's Scope 2 emissions?
In 2024, Tasly Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 106,327.17 tCOâ‚‚e without specifying the calculation method.
Has Tasly Pharmaceutical Group reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Tasly Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) rose by 11.06% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Tasly Pharmaceutical Group use for Scope 2 reporting?
In 2024, Tasly Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.
Tasly Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)